(Q40734041)
Statements
The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound (English)
Judith Gerlach
Reinhard Brossmer
Claus-Peter Danzer
1 reference
1 reference
1 reference
1 reference
1 reference